Skip to main content

Table 3 Chemokine scores by presence or absence of SLE clinical features

From: Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

Clinical features SLE clinical features present SLE clinical features absent P
  n Median (interquartile range) n Median (interquartile range)  
Renal 36 8.32 (1.43 to 19.41) 31 3.39 (-1.43 to +12.48) NS
Neurological 4 1.27 (-0.65 to +4.17) 63 6.23 (-0.42 to +15.60) NS
Arthritis 12 5.09 (-2.48 to +13.98) 55 5.93 (0.12 to 14.01) NS
Serositis 13 5.47 (0.67 to 38.08) 54 5.32 (-0.93 to +13.96) NS
Rash 22 2.37 (-2.27 to +13.96) 45 7.39 (0.89 to 15.634) NS
Mucosal ulcer 8 4.21 (1.95 to 14.33) 59 5.93 (-4.46 to +14.01) NS
Haematological 19 7.39 (-2.77 to +13.91) 48 5.09 (0.59 to 14.81) NS
Proteinuria 26 8.511 (2.01 to 23.25) 41 3.39 (-1.56 to +12.56) NS
Autoantibodies      
   Anti-dsDNA 37 5.47 (-0.32 to +14.17) 30 5.72 (-0.44 to +14.81) NS
   Anti-Ro 24 6.05 (1.85 to 13.96) 43 5.47 (-1.76 to +15.69) NS
   Anti-Sm 13 11.56 (3.89 to 23.82) 54 3.56 (-1.72 to +12.66) 0.0211
   Anti-RNP 23 10.28 (3.08 to 18.97) 44 2.95 (-1.72 to +12.56) 0.0212
   Anti-nucleosome 24 7.50 (1.63 to 15.69) 43 3.73 (-0.46 to +13.91) NS
Medical therapy      
   Predisone dose >30 mg/day 38 4.76 (-1.56 to +12.66) 29 7.72 (2.12 to 19.89) NS
   Immunosuppressants 28 9.98 (0.53 to 17.33) 39 3.08 (-1.43 to +12.65) NS
   CQ/HCQ 28 2.15 (-1.72 to +12.11) 39 8.92 (2.34 to 18.97) 0.0481
  1. anti-dsDNA, anti-double-stranded DNA; CQ, chloroquine; HCQ, hydrochloroquine; NS, not significant; SLE, systemic lupus erythematosus.